Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think!

Elsevier
Publish with us

Profile

Rosa Rademakers

RR

Rosa Rademakers

VIB Center for Molecular Neurology, Antwerp, Belgium

Rosa Rademakers is an internationally recognized leader in the genetics of frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease (AD). Her lab has identified and characterized numerous causal, risk and modifier genes, most notably in C9orf72, which she discovered as the genetic basis for a majority of ALS and FTD cases. In 2019, she relocated from Mayo Clinic in Jacksonville, FL, to lead the VIB Center for Molecular Neurology in Antwerp, Belgium. She received the Potamkin Prize in 2016 and in 2021 became the first female recipient of the Generet Award for Rare Diseases.

LinkedIn

VIB Center for Molecular NeurologyLab website